Vertex Pharmaceuticals (VRTX)

CapEx to Revenue

3.37%

Quarterly · Period ending:

VRTX logo

VRTX CapEx to Revenue

Latest reported3.37%
VRTX Quarterly CapEx/Revenue (0.00% → 3.37%)
High-resolution chart · PNG

VRTX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
3.3654%
4.4662%
4.6295%
3.3091%
4.9145%
1.4692%
3.1799%
2.4424%
2.8992%
9.2438%
2.3077%
1.6348%
2.3905%
1.7728%
1.4592%
2.3219%
2.4269%
3.0322%
2.9818%
2.6409%
2.7825%
4.1118%
2.9297%
11.3631%
1.1718%
1.2837%
1.186%
2.5574%
1.7378%
2.1016%
1.8068%
2.6655%
3.9369%
4.5691%
6.538%
32.5082%
3.2542%
1.5613%
3.2239%
3.3551%
3.6881%
3.0079%
2.9974%
2.8394%
8.0806%
7.6226%
10.1525%
5.1948%
8.4532%
13.1075%
4.1209%
8.3509%
0.5796%
5.0574%
8.3972%
6.3677%
3.7157%
1.4029%
1.656%
1.5147%
61.5526%
6.5841%
22.0194%
45.5138%
30.6306%
13.866%
22.3612%
19.0448%
24.0558%
27.4365%
20.1518%
33.2374%
13.785%
13.183%
10.1957%
19.3324%
34.4382%
8.9129%
7.6262%
13.1303%
36.2612%
19.0677%
8.0651%
12.2463%
12.8214%
11.3228%
9.5494%
6.825%
21.4875%
16.4221%
36.3071%
7.5251%
45.1923%
30.6913%
24.123%
36.174%
19.9528%
24.1111%
22.7618%
54.4193%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.